Cite
HARVARD Citation
Mangia, A. et al. (2017). Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion‐dependent thalassaemia and HCV genotype 1 or 4 infection. Alimentary pharmacology & therapeutics. 46 (4), pp. 424-431. [Online].